SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001358403-19-000026
Filing Date
2019-02-07
Accepted
2019-02-07 16:02:03
Documents
1
Period of Report
2019-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154957330959098.html 4  
1 FORM 4 wf-form4_154957330959098.xml 4 3553
  Complete submission text file 0001358403-19-000026.txt   5067
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Grossman William (Reporting) CIK: 0001730229 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 19575169